Product Information
OXYBUTYNIN CL ER 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1027 per EA under NDC 64980021001. Its NADAC has been published 495 times since Jan 4, 2017.
The High Outlier badge above means this manufacturer's average price in the Oxybutynin Chloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980021001
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206121On Market Since
9/27/2016
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 10 MG TABLET has been published 495 times since Jan 4, 2017, and over the history we have for it it has declined 84.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1027 per EA |
|---|---|
| All-time high | $0.6678 (Jan 11, 2017) |
| All-time low | $0.0837 (Nov 20, 2024) |
| 52-week high | $0.1089 |
| 52-week low | $0.1011 |
| Median price | $0.1984 |
| Average price | $0.2409 |
| Largest weekly change | +35.2% (Jun 19, 2024) |
| Weeks tracked | 495 |
| Tracking since | Jan 4, 2017 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1027 per EA (NDC 64980021001), effective Jun 24, 2026.
How has the price of OXYBUTYNIN CL ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has declined 84.6%. It has been tracked across 495 weekly CMS publications since Jan 4, 2017.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 10 MG TABLET?
Since Jan 4, 2017, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has ranged from a low of $0.0837 (Nov 20, 2024) to a high of $0.6678 (Jan 11, 2017), with a median of $0.1984 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 10 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as OXYBUTYNIN CL ER 10 MG TABLET, but none are currently priced below it.
Who manufactures OXYBUTYNIN CL ER 10 MG TABLET?
OXYBUTYNIN CL ER 10 MG TABLET (NDC 64980021001) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification